Software Healthcare Sector

Enovis

Market Cap: US$1.9b

Operates as a medical technology company focus on developing clinically differentiated solutions in the United States and internationally.

Select Medical Holdings

Market Cap: US$1.9b

Through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, and outpatient rehabilitation clinics in the United States.

Tarsus Pharmaceuticals

Market Cap: US$1.9b

A commercial stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for eye care in the United States.

Amicus Therapeutics

Market Cap: US$1.9b

A biotechnology company, focuses on discovering, developing, and delivering novel medicines for rare diseases in the United States and internationally.

Alphatec Holdings

Market Cap: US$1.9b

A medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders in the United States and internationally.

Genus

Market Cap: UK£1.4b

Operates as an animal genetics company in North America, Latin America, the United Kingdom, rest of Europe, the Middle East, Russia, Africa, and Asia.

ImmunityBio

Market Cap: US$1.8b

A commercial stage biotechnology company, develops next-generation therapies that bolster the natural immune systems to defeat cancers and infectious diseases.

LeMaitre Vascular

Market Cap: US$1.8b

Develops, manufactures, and markets medical devices and implants used in the field of vascular surgery in the Americas, Europe, the Middle Esat, Africa, and the Asia Pacific.

CG Oncology

Market Cap: US$1.8b

A late-stage clinical biopharmaceutical company, develops and commercializes backbone bladder-sparing therapeutics for patients with bladder cancer.

Travere Therapeutics

Market Cap: US$1.8b

A biopharmaceutical company, identifies, develops, and delivers therapies to people living with rare kidney and metabolic diseases in the United States.

UFP Technologies

Market Cap: US$1.8b

Designs and manufactures solutions for medical devices, sterile packaging, and other engineered custom products in the United States.

CONMED

Market Cap: US$1.8b

A medical technology company, develops, manufactures, and sells devices and equipment for surgical procedures in the United States and internationally.

Recursion Pharmaceuticals

Market Cap: US$1.8b

Operates as a clinical-stage biotechnology company, engages in the decoding biology and chemistry by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery in the United States.

Supernus Pharmaceuticals

Market Cap: US$1.8b

A biopharmaceutical company, develops and commercializes products for the treatment of central nervous system (CNS) diseases in the United States.

Schrödinger

Market Cap: US$1.8b

Develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications.

Bausch Health Companies

Market Cap: US$1.7b

Operates as a diversified specialty pharmaceutical and medical device company, develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, generic pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health in the United States and internationally.

Beam Therapeutics

Market Cap: US$1.7b

A biotechnology company, engages in the development of precision genetic medicines for patients suffering from serious diseases in the United States.

Arrowhead Pharmaceuticals

Market Cap: US$1.7b

Develops medicines for the treatment of intractable diseases in the United States.

Astrana Health

Market Cap: US$1.7b

A healthcare management company, provides medical care services in the United States.

Centessa Pharmaceuticals

Market Cap: US$1.7b

A clinical-stage pharmaceutical company, discovers, develops, and delivers medicines.

PACS Group

Market Cap: US$1.6b

Through its subsidiaries, operates skilled nursing facilities and assisted living facilities in the United States.

Oxford Nanopore Technologies

Market Cap: UK£1.2b

Engages in the research, development, manufacture, and commercialization of a novel generation of deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) sequencing technology that allows the real-time analysis of DNA or RNA.

GoodRx Holdings

Market Cap: US$1.6b

Offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States.

Agios Pharmaceuticals

Market Cap: US$1.6b

A biopharmaceutical company, discovers and develops medicines in the field of cellular metabolism in the United States.

Tivity Health

Market Cap: US$1.6b

Tivity Health, Inc. provides fitness and health products and solutions in the United States.

Arcutis Biotherapeutics

Market Cap: US$1.6b

A biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases.

GeneDx Holdings

Market Cap: US$1.6b

A genomics company, provides genetic testing services.

Endo

Market Cap: US$1.6b

A specialty pharmaceutical company, develops, manufactures, markets, and sells various pharmaceutical products in the United States and internationally.

Summerset Group Holdings

Market Cap: NZ$2.7b

Develops, owns, and operates integrated retirement villages in New Zealand and Australia.

IDEAYA Biosciences

Market Cap: US$1.6b

A precision medicine oncology company, discovers and develops targeted therapeutics for patient populations selected using molecular diagnostics in the United States.

Brookdale Senior Living

Market Cap: US$1.6b

Owns, manages, and operates senior living communities in the United States.

Janux Therapeutics

Market Cap: US$1.6b

A clinical stage biopharmaceutical company, develops immunotherapies based on Tumor Activated T Cell Engager (TRACTr) and Tumor Activated Immunomodulator (TRACIr) platforms technology to treat patients with cancer.

Edgewise Therapeutics

Market Cap: US$1.5b

A biopharmaceutical company, discovers, develops, and commercializes therapies for the treatment of muscle disorders.

AtriCure

Market Cap: US$1.5b

Develops, manufactures, and sells devices for surgical ablation of cardiac tissue, exclusion of the left atrial appendage, and temporarily blocking pain by ablating peripheral nerves to medical centers in the United States, the Asia-Pacific, and internationally.

Structure Therapeutics

Market Cap: US$1.5b

A clinical stage global biopharmaceutical company, develops and delivers novel oral small molecule therapeutics to treat various chronic diseases with unmet medical needs in the United States.

Disc Medicine

Market Cap: US$1.5b

A clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases in the United States.